When traditional approaches for weight loss, such as diet, exercise, and medications, fail as effective treatments for obesity, bariatric surgical procedures that restrict stomach size or lead to altered absorption of nutrients may be performed. While these procedures often result in significant, sustained weight loss, the benefits must be balanced against the short- and long-term risks of bariatric surgery. The Longitudinal Assessment of Bariatric Surgery (LABS) observational study was established by the LABS Consortium to assess the risks and health benefits associated with bariatric surgery and to identify aspects of the procedures and patient characteristics associated with optimal outcomes. The study is organized into three phases: LABS-1, which evaluates the short-term safety of bariatric surgery; LABS-2, which evaluates the longer-term safety and efficacy of bariatric surgery, in addition to examining patient characteristics associated with short- and intermediate-term outcomes; and LABS-3, which examines the psychosocial, quality-of-life, and health economics aspects of obesity, as well as the mechanisms of obesity-related diseases.

The LABS-1 study enrolled patients at least 18 years of age who underwent bariatric surgical procedures between March 2005 and December 2007 at LABS surgical centers. Participants underwent a pre-operative evaluation, during which data was collected on height, weight, blood pressure, comorbid conditions, and physical examination. Participant outcomes were recorded post-operatively. The primary outcome measure was a composite endpoint of any of the following occurring within 30 days of surgery: death; deep vein thrombosis (DVT) or venothromboembolism (VTE); reintervention using percutaneous, endoscopic, or operative techniques; or failure to discharge from the hospital. Of the 4776 patients who had a first-time procedure, over half had at least two co-morbid conditions. The 30-day mortality rate for Roux-en-y gastric bypass or laparoscopic adjustable gastric banding was 0.3%; 4.3% of participants had at least one major adverse outcome. The LABS-1 study showed that the short-term risk of death and adverse outcome after bariatric surgery was low, particularly when contrasted with patient characteristics.

Following conclusion of the LABS-1 study, the LABS-2 study was initiated to examine the longer-term safety, outcomes, and durability of health changes of bariatric surgery. The primary objectives of the LABS-2 study were to determine weight, medical, surgical, and behavioral outcomes, including incidence and remission of co-morbid conditions, and to evaluate patient, procedure, and other characteristics that were associated with these outcomes. The cohort included patients who underwent bariatric surgery at LABS clinical centers through 2009.

Clinical assessments and detailed interviews and questionnaires are administered at several post-operative time points (30 days, 6 months, 12 months following surgery, and annually thereafter) to assess risks of surgery and changes in clinical, metabolic, and psychosocial characteristics in patients following bariatric surgery. Detailed data about the surgical procedure and peri- and post-operative care are also collected to determine if components of the surgical procedure, care, and/or clinical/demographic patient characteristics are associated with post-operative risks and changes in patient status.

An ancillary study from LABS-2 regarding psychosocial issues associated with weight loss was conducted at two of the LABS study centers, and a set of control participants were recruited from primary care practices outside of the LABS consortium. The overall duration of this ancillary study was 48 months with the goal of assessing changes in sexual function and sex hormones in the two groups at predetermined follow-up visits.

An ancillary study from LABS-3 regarding psychosocial issues associated with bariatric surgery was conducted at three of the LABS study centers with participants that were previously enrolled in LABS-1 and LABS-2. This prospective cohort ancillary study aimed to understand the mental health impacts of bariatric surgery and changes in mental health outcomes over a 7-year follow-up period. Data were collected on psychosocial issues such as eating disorders, substance abuse, affective disorders, and cognitive function.

The current data package available includes full data from LABS-1 and LABS-2, and ancillary data from LABS-2 and LABS-3.

The NAVER LABS localization datasets are 5 new indoor datasets for visual localization in challenging real-world environments. They were captured in a large shopping mall and a large metro station in Seoul, South Korea, using a dedicated mapping platform consisting of 10 cameras and 2 laser scanners. In order to obtain accurate ground truth camera poses, we used a robust LiDAR SLAM which provides initial poses that are then refined using a novel structure-from-motion based optimization. The datasets are provided in the kapture format and contain about 130k images as well as 6DoF camera poses for training and validation. We also provide sparse Lidar-based depth maps for the training images. The poses of the test set are withheld to not bias the benchmark.

Laboratory testing service companies experienced significant shifts over the past few years, rooted largely in the ebb and flow of economic conditions. During the pandemic, the industry saw unique growth patterns, with health spending surging despite a general downturn in other sectors such as construction. This strange dichotomy was driven by an increased need for health-related testing services, maintaining some buoyancy in overall revenue in 2020. However, post-pandemic recovery didn't uniformly benefit all segments, with corporate profit rises not immediately translating into robust investment growth due to low research and development (R&D) expenditures. In 2022, the rebound in R&D expenditure and changes in workplace policies toward in-person attendance spurred notable revenue gains. Companies started channeling their profit into new ventures, including laboratory testing, while construction demand picked up. Between 2023 and 2024, the Federal Reserve raised interest rates to combat inflation, which constrained household credit and slowed consumer spending. This led to reduced business sales and cuts in nonessential expenses like R&D, slowing revenue growth. Despite these challenges, high demand from construction companies bolstered the sector in 2023. By 2024, solid GDP growth eased recessionary fears, bolstering demand for the industry’s services. Growth in revenue during these years also contributed to a jump in profit over the past few years. Overall, revenue for laboratory testing service providers has expanded at a CAGR of 2.5% over the past five years, reaching $33.4 billion in 2025. This includes a 2.5% rise in revenue in that year. Looking forward, the next five years promise continued growth for laboratory testing companies, though not without hurdles. Economic projections point toward stable GDP growth, boosting consumer spending and corporate profit—both favorable conditions for the industry. But potential shifts in fiscal and trade policies, including tariffs and interest rates, loom as threats that could unsettle the market. Furthermore, rising R&D spending augurs well for demand for lab testing, as industries push the envelope on new technology and product development. Nevertheless, public sector R&D budget cuts could stymie some opportunities, nudging companies to increasingly court private sector clientele. As labs integrate AI and automation, larger players stand to gain more market share, potentially leaving smaller labs to adapt through cost-cutting and innovation to remain competitive. Overall, revenue for laboratory testing service companies is forecast to swell at a CAGR of 2.4% over the next five years, reaching $37.6 billion in 2030.

After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations.

This time series dataset includes viral COVID-19 laboratory test [Polymerase chain reaction (PCR)] results from over 1,000 U.S. laboratories and testing locations including commercial and reference laboratories, public health laboratories, hospital laboratories, and other testing locations. Data are reported to state and jurisdictional health departments in accordance with applicable state or local law and in accordance with the Coronavirus Aid, Relief, and Economic Security (CARES) Act (CARES Act Section 18115).

Data are provisional and subject to change.

Data presented here is representative of diagnostic specimens being tested - not individual people - and excludes serology tests where possible. Data presented might not represent the most current counts for the most recent 3 days due to the time it takes to report testing information. The data may also not include results from all potential testing sites within the jurisdiction (e.g., non-laboratory or point of care test sites) and therefore reflect the majority, but not all, of COVID-19 testing being conducted in the United States.

Sources: CDC COVID-19 Electronic Laboratory Reporting (CELR), Commercial Laboratories, State Public Health Labs, In-House Hospital Labs

Data for each state is sourced from either data submitted directly by the state health department via COVID-19 electronic laboratory reporting (CELR), or a combination of commercial labs, public health labs, and in-house hospital labs. Data is taken from CELR for states that either submit line level data or submit aggregate counts which do not include serology tests.

Personalized medicine is reshaping the costs and services of diagnostic and medical labs, necessitating new strategies for growth and competitiveness. There is a rising demand for labs capable of advanced genetic testing, requiring cutting-edge technology and specialized expertise in genetic data analysis. Although these tests have high upfront costs, they can potentially lower long-term healthcare expenses and boost the overall value of laboratory services. As demand grows, labs must effectively manage operating expenses, leading to a trend of consolidation. Mergers allow more extensive networks to achieve economies of scale, invest in new technologies and offer comprehensive services for sustained growth. As new technologies like point-of-care testing (POCT) present ongoing competitive challenges, industry revenues have grown at a CAGR of 2.6% to reach $87.5 billion through 2025, experiencing a 3.6% gain in 2025 alone. The fee-for-service model is gradually being replaced by a managed-cost healthcare framework, which emphasizes fixed service rates and preventive care to reduce overall expenses and these regulatory requirements have increased operational costs for labs. Consolidation among essential buyers—physicians, insurers, employers and pharmaceutical companies—has strengthened their bargaining power, enabling them to drive down prices and internalize testing, lessening the need for external labs. To address the challenges, labs must innovate quickly and explore collaborative opportunities to reduce costs. Technology will continue to reshape industry competition and strategy. Labs are adapting by leveraging automation, AI and digital health technologies that are becoming standard. Robotic automation allows labs to handle more tests with fewer errors, providing a competitive edge. AI revolutionizes data interpretation, reducing the need for specialized human labor and cutting costs while improving accuracy and resource optimization. Telehealth alters patient interactions, encouraging remote access to test results and consultations. To remain relevant, labs must integrate seamlessly with telehealth systems, embrace automation and seek associations or mergers to gain economies of scale. Despite the competitive pressures and challenges, the industry is expected to enjoy continued growth, with revenue strengthening at a CAGR of 3.4% to reach $103.6 billion by 2030, with profit stable.

Virtual IT Labs Software Market Outlook

The global market size of Virtual IT Labs Software was valued at $1.5 billion in 2023, and it is projected to reach $4.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 13.5% over the forecast period. This market is experiencing significant growth due to the increasing demand for remote learning and training solutions, driven by the digital transformation initiatives undertaken by organizations worldwide.

One of the primary growth factors of the Virtual IT Labs Software market is the increasing adoption of e-learning and virtual training solutions across various industries. With the rapid advancement of technology, organizations are increasingly relying on virtual labs to train employees, reduce costs, and improve efficiency. Virtual IT labs provide a scalable and flexible environment for hands-on learning, allowing users to experiment and practice in a risk-free setting. This has led to a surge in demand for virtual lab solutions in educational institutions, corporate training programs, and IT certifications.

Another significant driver for the market is the growing need for cybersecurity training. As cyber threats become more sophisticated and prevalent, organizations are investing heavily in cybersecurity training to protect their digital assets. Virtual IT labs offer a controlled environment where individuals can practice and improve their cybersecurity skills without risking real-world data. This has created a substantial demand for virtual labs that specialize in cybersecurity training, contributing to the market's growth.

The rise of cloud technology is also playing a crucial role in the expansion of the Virtual IT Labs Software market. Cloud-based virtual labs offer several advantages, including reduced costs, scalability, and accessibility. These labs can be accessed from anywhere with an internet connection, making them ideal for remote and distributed teams. The increasing adoption of cloud technology by enterprises is expected to continue driving the growth of cloud-based virtual IT lab solutions over the forecast period.

From a regional perspective, North America is expected to dominate the Virtual IT Labs Software market, owing to the high adoption rate of advanced technologies and the presence of major market players in the region. Europe and Asia Pacific are also anticipated to witness substantial growth, driven by the increasing investments in digital education and corporate training programs. Emerging economies in Latin America and the Middle East & Africa are gradually adopting virtual IT lab solutions, further contributing to the market's expansion.

Component Analysis

In the Virtual IT Labs Software market, the component segment is categorized into Software and Services. The software component is a significant part of the market, encompassing various platforms and solutions designed to create and manage virtual IT labs. These software solutions offer features such as virtual environments, simulation tools, and interactive learning modules. The demand for robust and user-friendly software solutions is increasing as organizations seek to provide comprehensive training programs that can be easily implemented and managed.

The services component includes consulting, implementation, support, and maintenance services associated with virtual IT lab solutions. As organizations adopt virtual labs, they require expertise to integrate these solutions into their existing systems. Service providers offer valuable support in customizing and optimizing virtual labs to meet specific training needs. Additionally, ongoing maintenance and support services ensure the smooth functioning of virtual lab environments, which is crucial for minimizing downtime and maximizing the effectiveness of training programs.

One significant trend in the software segment is the integration of advanced technologies such as artificial intelligence (AI) and machine learning (ML) to enhance the learning experience. AI-powered virtual labs can provide personalized training modules, analyze user performance, and offer real-time feedback, making the learning process more interactive and effective. This technological advancement is expected to drive the demand for sophisticated virtual IT lab software over the forecast period.

On the services side, the market is witnessing a growing demand for managed services. Organizations are increasingly outsourcing the management of their virtual IT labs to specialized service providers to reduce o

The Environmental Lab Accreditation Program (ELAP) of the Division of Drinking Water, California State Water Resources Control Board certifies laboratories for the testing of drinking water in a number of pollutant categories. The ELAP program's mission is to implement a sustainable accreditation program that ensures laboratories generate environmental and public health data of known, consistent, and documented quality to meet stakeholder needs. Through effective program implementation and continuous improvement of ELAP, California will utilize the highest quality scientific data as a foundation for its environmental and public health programs and decisions.This layer is updated nightly to provide the public a monthly update of lab locations along with their current testing certifications licensed by the program. More information can be found at https://www.waterboards.ca.gov/drinking_water/certlic/labs/Email elapca@waterboards.ca.gov for questions or concerns

North America Diagnostic Labs Market is estimated to be USD 55.7 Billion by 2034 and is anticipated to register a CAGR of 4.0% during the forecast period.

Data of public access coputer labs in Austin

Hirai-Labs/alpr-vlm-instruct-dataset dataset hosted on Hugging Face and contributed by the HF Datasets community

This statistic depicts prescription sales of the leading independent vision labs in the United States in 2017. In that year, Walman Optical was the leading independent vision lab in the United States with prescription sales that amounted to 180 million U.S. dollars.

Dataset Card for Dataset Name

This dataset card aims to be a base template for new datasets. It has been generated using this raw template.

  Dataset Details





  Dataset Description

Curated by: [More Information Needed] Funded by [optional]: [More Information Needed] Shared by [optional]: [More Information Needed] Language(s) (NLP): [More Information Needed] License: [More Information Needed]

  Dataset Sources [optional]

Repository: [More… See the full description on the dataset page: https://huggingface.co/datasets/TUDB-Labs/medical-qa.

pythia-12b-neuron-dataset-examples

This dataset contains the top 64 highest activating dataset examples for each MLP neuron in Pythia-12b. The dataset examples are all 16 tokens long. See https://confirmlabs.org/posts/dreaming.html for details. Columns:

layer: the layer of the neuron neuron: the index of the neuron rank: the rank of the example activation: the activation of the neuron on the example position: the token position for which the neuron is maximally activated. text: the… See the full description on the dataset page: https://huggingface.co/datasets/Confirm-Labs/pythia-12b-neuron-dataset-examples.

The global Online Science Labs market is projected to reach USD XXX million by 2033, exhibiting a CAGR of XX% during the forecast period 2025-2033. The growth is attributed to the increasing adoption of online learning platforms in educational institutions, the rising demand for interactive and engaging science learning experiences, and the growing popularity of remote learning due to the COVID-19 pandemic. Additionally, the availability of numerous cost-effective and user-friendly online science labs further contributes to the market growth. The market is segmented into various categories, including application, company, and region. Based on application, the research institution segment is expected to hold the largest market share due to the extensive use of online science labs for research and development activities. In terms of region, North America is projected to dominate the market, followed by Europe and Asia Pacific. Key market players include VRLab Academy, Labster, PraxiLabs, Annenberg Learner, COMSOL, PhET, Science Interactive, PNX Labs, EON Reality, and Learnetic. These companies offer a wide range of online science lab solutions tailored to meet the diverse needs of educational institutions and individual learners.

IndicST: Indian Multilingual Translation Corpus For Evaluating Speech Large Language Models

  Introduction

IndicST, a new dataset tailored for training and evaluating Speech LLMs for AST tasks (including ASR and TTS), featuring meticulously curated, automatically, and manually verified synthetic data. The dataset offers 10.8k hrs of training data and 1.13k hrs of evaluation data.

  Use-Cases





  ASR (Speech-to-Text)

Transcribing Indic languages Handling… See the full description on the dataset page: https://huggingface.co/datasets/krutrim-ai-labs/IndicST.

The dataset presents a list of laboratories set up in the humanities, digital humanities, and media studies within universities across the world in 1983-2018. The data are collected and organized in an interactive map designed in the digital StoryMapJS tool, creating a valuable visible representation of the laboratory concept from a geographical and historical perspective. Based on the interactive map, I analyze the history of the laboratory in the humanities within a global context from the 1980s to 2018. The dataset includes 214 laboratories.

Data collection

I identified laboratories by using different resources such as universities’ websites, articles, and research projects. Besides, I sent a questionnaire to the most relevant networks in October 2018 to identify even more labs created in (digital) humanities and media studies at universities.

Data organization

I collected data about each lab based on its website and other resources. I extracted the following data: year established, year ended (if applicable), lab’s name, university, city, country, affiliation and location (if provided), disciplines and keywords (based on labs’ statements and projects and aiming to situate a lab), selected projects (if provided), purpose (a short quotation of a lab’s statement published on its website), website, and geographical latitude and longitude. I organized all the data in chronological order according to year established in Google Sheets. Next, I used StoryMapJS, a free tool designed by the Northwestern University’s Knight Lab, to map my data.

The Virtual and Remote Laboratories market, valued at $789.81 million in 2025, is experiencing robust growth, projected to expand significantly by 2033. A Compound Annual Growth Rate (CAGR) of 11.95% indicates strong market momentum driven by several key factors. The increasing accessibility and affordability of high-speed internet, coupled with the growing adoption of e-learning platforms and a surge in demand for flexible and cost-effective educational and research solutions, are pivotal drivers. Furthermore, the rising need for hands-on experience in scientific and technical fields, even in remote locations or with limited access to physical laboratory facilities, fuels market expansion. The market is segmented by type into Remote and Virtual Laboratories, catering to both institutional and individual learning needs. Leading companies are actively employing competitive strategies focused on developing innovative software and hardware solutions, strengthening partnerships, and expanding their global reach. While challenges such as ensuring data security and maintaining the quality of virtual learning experiences exist, the market's overall trajectory points towards sustained growth, primarily fueled by technological advancements and changing educational paradigms. Europe, particularly Germany, the UK, France, and Italy, represents a substantial market share, reflecting the region's advanced technological infrastructure and strong emphasis on education and research. The competitive landscape is populated by a mix of established players such as Merck KGaA and Pearson Plc, and innovative startups focused on specialized niche areas. These companies are investing heavily in research and development to enhance the functionality and accessibility of virtual and remote laboratory solutions. This includes improving user experience, integrating advanced simulation technologies, and expanding support for various scientific disciplines. The long-term forecast predicts continued market expansion, driven by ongoing technological advancements, increasing government support for digital learning initiatives, and the broadening acceptance of virtual and remote laboratories as a viable alternative to traditional physical laboratories.

U.S. Diagnostic Labs Market is predicted to have a value of USD 51.1 Billion By 2034, with an annualized growth rate (CAGR) of 2.0%.

Incorporating authentic research experiences into undergraduate labs, while shown to be particularly effective at engaging and retaining students in STEM majors, can be difficult to accomplish within the constraints of resource availability or cost, and time limitations. One area that is particularly amenable to adaptation for undergraduate lab classes is the discovery and validation of targets of microRNAs (miRs). The human genome encodes several hundred, possibly several thousand miRs, each of which is a 22 nucleotide long RNA molecule capable of regulating the expression of multiple target genes. miRs have been shown to be critical during development, for human health and disease, and are currently being investigated as both therapeutic agents, as well as possible drug targets. A lack in understanding the mechanisms by which miRs recognize their targets makes computer-based predictions of miR targets quite inaccurate, necessitating experimental verification of such predictions. In this lesson, we describe an easily adaptable lab module that can be used in existing undergraduate molecular biology lab courses to conduct authentic scientific research. Students use a variety of databases to identify likely candidate genes whose expression may be altered by a given miR, and then experimentally test their predictions in human cells. This inquiry-based module gives students a taste of real scientific research and excites them about the possibility that, even as a student, they have the potential to contribute to this cutting edge research.

Global Clinical Laboratory Services Market size valued at US$ 267.20 Billion in 2023, set to reach US$ 388.69 Billion by 2032 at a CAGR of about 3.8% from 2024 to 2032.